Dementia talking points

21 Septiembre 2017

The problem

WHO estimates that dementia affects around 47 million people worldwide (or roughly 5% of the world’s elderly population). It is one of the major causes of disability and dependency among older people.

Globally nearly 10 million people develop dementia each year; one new case every three seconds.

The number of people with dementia is set to triple between 2015 and 2050.

Nearly 60% of people with dementia currently live in low- and middle-income countries and most new cases (71%) are expected to occur in those countries.

In 2015, the estimated costs of dementia to society were US$ 818 billion.

This is expected to more than double by 2030, to US$ 2 trillion.

Dementia is underdiagnosed worldwide and when it is diagnosed, it is generally late in the progression of the disease.

The gap between the need for treatment and care for dementia, and the provision of these services is substantial.

Families and friends provide most of the care. Caring for someone with dementia without training and support network can be mentally and financially difficult.

Diagnostics, treatment, care and cure

There is no treatment currently available to cure dementia or to alter its progressive course.

Research involving the pharmaceutical industry, governments and academics is ongoing for better diagnostics and a cure. Many studies are ongoing and many different products are in the pipeline.

Much can be done, however, to improve the lives of people with dementia and their carers and families. The principal goals for dementia care are:

Early diagnosis

Optimizing physical health, cognition, activity and well-being

Identifying and treating accompanying physical illness

Detecting and preventing or coping with challenging behaviour

Providing information, skills training and long-term support, such as enabling them to take time out for themselves.

What WHO is doing

Developed the Global action plan on the public health response to dementia, adopted by the World Health Assembly in May this year.

The Plan provides guidance to governments, development agencies, research institutions and civil society on the development of policies on dementia across health, social and other sectors, and prevention and promotion strategies.

Establishing the Global Dementia Observatory to function as an international surveillance platform for policy-makers and researchers to facilitate and enable monitoring and sharing of information on dementia policies, service delivery, epidemiology and research. Launch is planned for the end of 2017.

Developing a Dementia Friendly Initiative Toolkit to provide practical guidance on how to assess and improve dementia-friendliness of physical and social environments.

Countries at the forefront of creating dementia-friendly communities – from local initiatives to country-wide programmes -  include Australia, Japan and the UK.

The UK and Japan have agreed to take forward:

Promotion of policies on age- and dementia-friendly communities and dementia friends programmes

Creation of a network to support information sharing

Support for international joint research on the benefits and effectiveness of dementia-friendly communities and dementia friends programmes

Developing dementia risk reduction guidelines for countries to increase behaviours that can prevent or delay dementia.

Developed iSupport, www.isupportfordementia.org, an e-health solution that provides information and skills training for carers of people living with dementia. The first study of the usability and effectiveness of iSupport is currently ongoing in India.

Background

Dementia is an umbrella term for several progressive diseases affecting memory, cognitive abilities and behaviour that interfere significantly with a person’s ability to maintain usual daily activities.

The most common types of dementia are Alzheimer’s disease and vascular dementia.

Dementia is not an inevitable consequence of ageing.

 

For the occasion we have released new materials relating to the Global action plan on the public health response to dementia http://apps.who.int/gb/ebwha/pdf_files/WHA70/A70_28-en.pdf?ua=1&ua=1, endorsed by the World Health Assembly in May 2017. 

All products are accessible from the top story on http://www.who.int/mental_health/neurology/dementia/en/

Lastly, attached are talking points for your use in responding to the media and other audiences. Another resource is our fact sheet on dementia http://www.who.int/mediacentre/factsheets/fs362/en/

 

 



Quiénes Somos

La Sociedad Española de Medicina Geriátrica tiene carácter privado y carece de fines lucrativos. Entre sus objetivos están la promoción del estudio y desarrollo de la Geriatría; la contribución, a través de una labor de investigación y asesoramiento, en la solución de los problemas que plantea el perfeccionamiento de la asistencia geriátrica en España y el apoyo a la formación de todos aquellos profesionales implicados en el cuidado y atención de los ancianos.

más sobre nosotros

Formación y docencia

La SEMEG desea una formación continuada de sus profesionales a través de cursos, conferencias, congresos y cualquier herramienta que sirva para mejorar a los profesionales y su atención al anciano.

ver más

Síguenos en TWITTER

  • https://t.co/c6yCqPr7h5
    26/11/2022
  • https://t.co/A3bW4wFwBT
    26/11/2022
  • https://t.co/XNbxQNa9Ym
    26/11/2022
  • RT @vickymgibson: Excellent talk from Dr Noam Winter on pre-op opioid use in surgical pts: - Tapering needs to be patient centred & led, &…
    25/11/2022
  • RT @vickymgibson: Dr John Geddes talks about why shared decision making is imperative in older patients, and the barriers to overcome @ANZ
    25/11/2022
  • #𝗣𝗶𝗹𝗱𝗼𝗿𝗮𝘀𝗚𝗕𝗘 | La afectación cognitiva tras cirugía mayor ortopédica en el adulto mayor. El papel de depósitos de B… https://t.co/94VjNacPKa
    𝗣𝗶𝗹𝗱𝗼𝗿𝗮𝘀𝗚𝗕𝗘
    24/11/2022
  • ¿Se puede prevenir la fragilidad❓ Contamos con medidas para prevenir la aparición de la fragilidad, detectarla de m… https://t.co/pXnir7miXh
    24/11/2022
  • RT @JNHA6: Nivet, C., Duhalde, V., Beaurain, M. et al. Fecal Microbiota Transplantation for Refractory Clostridioides Difficile Infection I…
    23/11/2022

¿Aún no eres socio de SEMEG?
Conoce todas las ventajas